Page last updated: 2024-11-02

pirenzepine and Adult Neuronal Ceroid Lipofuscinosis

pirenzepine has been researched along with Adult Neuronal Ceroid Lipofuscinosis in 1 studies

Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.

Research Excerpts

ExcerptRelevanceReference
"Patients with juvenile neuronal ceroid lipofuscinosis (JNCL) often have severe psychiatric symptoms."2.70New antidepressive and antipsychotic drugs in juvenile neuronal ceroid lipofuscinoses--a pilot study. ( Aberg, LE; Aronen, ET; Bäckman, ML; Santavuori, PR, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bäckman, ML1
Aberg, LE1
Aronen, ET1
Santavuori, PR1

Trials

1 trial available for pirenzepine and Adult Neuronal Ceroid Lipofuscinosis

ArticleYear
New antidepressive and antipsychotic drugs in juvenile neuronal ceroid lipofuscinoses--a pilot study.
    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2001, Volume: 5 Suppl A

    Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines;

2001